Dr. Rubina Mian has led research teams in diverse sectors, including an international pharmaceutical company and academia. She has also served as a Non-Executive Director in the NHS. She pioneered a groundbreaking platform technology that involves a 10-minute fingertip test designed to unravel immune cell communication by decoding neutrophil signals. This innovative approach revolutionises personalised medicine, enabling powerful personalised disease tracking in real-time. Her invention is radically different from existing technologies as it is completely mobile, allowing access without the need for expensive hospital or lab-based procedures. It is a world first, as recognised by internationally granted patents.